NCT04525157Phase 2Completed

Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)

Study sponsor: Clinuvel Pharmaceuticals Limited

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2016-02-02Actual
Enrollment · participants21Actual
Source updated2023-09-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.